NASDAQ: MLTX
MoonLake ImmunotherapeuticsCIK 0001821586 · Pharmaceutical Preparations
Small by assets
Assets $400M
as of Jun 10, 2026
8-K
Filed Jun 9, 2026
· Period ending Jun 4, 2026
Summary not yet generated.
8-K
Filed Jun 1, 2026
· Period ending May 22, 2026
Summary not yet generated.
Partner
Trade MLTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
10-Q
Filed May 11, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed May 11, 2026
· Period ending May 10, 2026
Summary not yet generated.
10-K
Filed Feb 25, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Nov 5, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-K
Filed Feb 26, 2025
· Period ending Dec 31, 2024
Summary not yet generated.